Yüklüyor......
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
Irritable bowel syndrome (IBS) is one of the most common disorders of the gut-brain axis, which affects approximately 4% of the global population. The Rome IV criteria define IBS as chronic or recurrent abdominal pain associated with altered bowel habits. Patients can be categorized in four subtypes...
Kaydedildi:
| Yayımlandı: | Front Pharmacol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7935509/ https://ncbi.nlm.nih.gov/pubmed/33679391 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.629026 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|